Af-2 activity and recruitment of steroid receptor coactivator 1 to the estrogen receptor depend on a lysine residue conserved in nuclear receptors

Molecular and Cellular Biology

Volumn 17, Issue 4, 1997, Pages 1832-1839

  Henttu, Pirkko M A ^a   Kalkhoven, Eric ^a   Parker, Malcolm G ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; ESTROGEN RECEPTOR; LYSINE; STEROID RECEPTOR; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; BINDING SITE; DNA BINDING; GENE MUTATION; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; TRANSACTIVATION; TRANSCRIPTION INITIATION;

ANIMALIA;

EID: 0030950531     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.17.4.1832     Document Type: Article

References (50)

1. Baniahmad, A., I. Ha, D. Reinberg, S. Tsai, M. J. Tsai, and B. W. O'Malley. 1993. Interaction of human thyroid-hormone receptor-beta with transcription factor TFIIB may mediate target gene derepression and activation by thyroid-hormone. Proc. Natl. Acad. Sci. USA 90:8832-8836.
2. Barettino, D., M. D. V. Ruiz, and H. G. Stunnenberg. 1994. Characterization of the ligand-dependent transactivation domain of thyroid-hormone receptor. EMBO J. 13:3039-3049.
3. Beato, M. 1989. Gene regulation by steroid hormones. Cell 56:335-344.
4. Bourguet, W., M. Ruff, P. Chambon, H. Gronemeyer, and D. Moras. 1995. Crystal-structure of the ligand-binding domain of the human nuclear receptor RXR-alpha. Nature 375:377-382.
5. Cavaillès, V., S. Dauvois, P. S. Danielian, and M. G. Parker. 1994. Interaction of proteins with transcriptionally active estrogen receptors. Proc. Natl. Acad. Sci. USA 91:10009-101113.
6. Cavaillès, V., S. Dauvois, F. L'Horset, G. Lopez, S. Hoare, P. J. Kushner, and M. C. Parker. 1995. Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J. 14:3741-3751.
7. Chakravarti, D., V. J. LaMorte, M. C. Nelson, T. Nakajima, I. G. Schulman, H. Juguilon, M. Montminy, and R. M. Evans. 1996. Role of CBP/P300 in nuclear receptor signalling. Nature 383:99-103.
8. Chang, C., and J. Kokontis. 1988. Identification of a new member of the steroid receptor super-family by cloning and sequence analysis. Biochem. Biophys. Res. Commun. 155:971-977.
9. Chen, C., and H. Okayama. 1987. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7:2745-2752.
10. Danielian, P. S., R. White, J. A. Lees, and M. G. Parker. 1992. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J. 11:1025-1033.
11. Durand, B., M. Saunder, C. Gaudon, B. Roy, R. Losson, and P. Chambon. 1994. Activation function 2 (AF-2) of retinoic acid receptor and 9-cis retinoic acid receptor: presence of a conserved autonomous constitutive activating domain and influence of the nature of the response element on AF-2 activity. EMBO J. 13:5370-5382.
12. Evans, R. M. 1988. The steroid and thyroid hormone receptor superfamily. Science 240:889-895.
13. Fawell, S. E., J. A. Lees, R. White, and M. G. Parker. 1990. Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptor. Cell 60:953-962.
14. Fawell, S. E., R. White, S. Hoare, M. Sydenham, M. Page, and M. G. Parker. 1990. Inhibition of estrogen receptor-DNA binding by the 'pure' antiestrogen ICI 164,384 appears to be mediated by impaired receptor dimerization. Proc. Natl. Acad. Sci. USA 87:6883-6887.
15. Forman, B. M., C. Yang, M. Au, J. Casanova, J. Ghysdael, and H. H. Samuels. 1989. A domain containing a leucine-zipper-like motif mediates novel in vivo interactions between the thyroid hormone and retinoic acids receptors. Mol. Endocrinol. 3:1610-1626.
16. Halachmi, S., E. Marden, G. Martin, H. MacKay, C. Abbondanza, and M. Brown. 1994. Estrogen receptor-associated proteins - possible mediators of hormone-induced transcription. Science 264:1455-1458.
17. Ing, N. H., J. M. Beekman, S. Y. Tsai, M.-J. Tsai, and B. W. O'Malley. 1992. Members of the steroid hormone receptor superfamily interact with TFIIB (S300-II). J. Biol. Chem. 267:17617-17623.
18. 1130 is present in a distinct TFIID complex and is required for transcriptional activation by the estrogen receptor. Cell 79:107-117.
19. Joyeux, A., V. Cavaillès, P. Balaguer, and J. C. Nicolas. 1996. RIP 140 enhances nuclear receptor-dependent transcription in vivo, in yeast. Mol. Endocrinol. 11:193-202.
20. Kalkhoven, E. Unpublished data.
21. Kamei, Y., L. Xu, T. Heinzel, J. Torchia, R. Kurokawa, B. Gloss, S.-C. Lin, R. A. Heyman, D. W. Rose, C. K. Glass, and M. G. Rosenfeld. 1996. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85:403-414.
22. Kliewer, S. A., K. Umesono, D. J. Mangelsdorf, and R. M. Evans. 1992. Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling. Nature 355:446-149.
23. Lahooti, H., R. White, S. A. Hoare, D. Rahman, D. J. C. Pappin, and M. G. Parker. 1995. Identification of phosphorylation sites in the mouse estrogen-receptor. J. Steroid Biochem. 55:305-313.
24. Law, S. W., O. M. Conneely, F. J. DeMayo, and B. W. O'Malley. 1992. Identification of a new brain-specific transcription factor, NURR1. Mol. Endocrinol. 6:2129-2135.
25. Le Douarin, B., C. Zechel, J. M. Garnier, Y. Lutz, L. Tora, B. Pierrat, D. Heery, H. Gronemeyer, P. Chambon, and R. Losson. 1995. The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J. 14:2020-2033.
26. Lee, J. W., F. Ryan, J. C. Swaffield, S. A. Johnston, and D. D. Moore. 1995. Interaction of thyroid-hormone receptor with a conserved transcriptional mediator. Nature 374:91-94.
27. Leid, M., P. Kastner, R. Lyons, H. Nakshatri, M. Saunders, T. Zacharewski, Y.-Y. Chen, A. Staub, J.-M. Garnier, S. Mader, and P. Chambon. 1992. Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell 68:377-395.
28. L'Horset, F., S. Dauvois, D. M. Heery, V. Cavaillès, and M. G. Parker. 1996. RIP-140 interacts with multiple nuclear receptors by means of two distinct sites. Mol. Cell. Biol. 16:6029-6036.
29. Lillie, J. W., and M. R. Green. 1984. Transcription activation by the adenovirus E1a protein. Nature 338:39-44.
30. Mangelsdort, D. J., C. Thummel, M. Beato, P. Herrlich, G. Schutz, K. Umesono, B. Blumberg, P. Kastner, M. Mark, P. Chambon, and R. E. Evans. 1995. The nuclear receptor superfamily: the second decade. Cell 83:835-839.
31. Marks, M. S., P. L. Hallenbeck, T. Nagata, J. H. Segars, E. Appella, V. M. Nikodem, and K. Ozato. 1492. H-2RIIBP (RXRβ) heterodimerization provides a mechanism for combinatorial diversity in the regulation of retinoic acid and thyroid hormone responsive genes. EMBO J. 11:1419-1435.
32. Milbrandt, J. 1988. Nerve growth factor induces a gene homologous to the glucocorticoid receptor gene. Neuron 1:183-188.
33. O'Donnell, A. L., and R. J. Koenig. 1990. Mutational analysis identifies a new functional domain of the thyroid hormone receptor. Mol. Endocrinol. 4:715-720.
34. Onate, S. A., S. Y. Tsai, M.-J. Tsai, and B. W. O'Malley. 1995. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270:1354-1357.
35. Pakdel, F., J. C. Reese, and B. S. Katzenellenbogen. 1993. Identification of charged residues in an N-terminal portion of hormone-binding domain of the human estrogen-receptor important in transcriptional activity of the receptor. Mol. Endocrinol. 7:1408-1417.
36. Parker, M. G. 1993. Steroid and related receptors. Curr. Opin. Cell Biol. 5:499-504.
37. Quigley, C. A., A. De Bellis, K. B. Marschke, M. K. El-Awady, E. M. Wilson, and F. S. Fench. 1995. Androgen receptor defects: historical, clinical, and molecular perspectives. Endocrine Rev. 16:271-321.
38. Renaud, J.-P., N. Rochel, M. Ruff, V. Vivat, P. Chambon, H. Gronemeyer, and D. Moras. 1995. Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid. Nature 378:681-689.
39. Saatcioglu, F., P. Bartunek, T. Deng, M. Zenke, and M. Karin. 1993. A conserved C-terminal sequence that is deleted in v-ErbA is essential for the biological activities of c-ErbA (the thyroid hormone receptor). Mol. Cell. Biol. 13:3675-3685.
40. Sadovsky, Y., P. Webb, G. Lopez, J. D. Baxter, V. Cavailles, M. G. Parker, and P. J. Kushner. 1995. Transcriptional activators differ in their responses to overexpression of TATA-box-binding protein. Mol. Cell. Biol. 15:1554-1563.
41. Sleigh, M. J. 1986. A nonchromatographic assay for expression of the chloramphenicol acetyltransferase gene in eucaryotic cells. Anal. Biochem. 156: 251-256.
42. Smith, C. L., S. A. Onate, M.-J. Tsai, and B. W. O'Malley. 1996. CREB binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptor-dependent transcription. Proc. Natl. Acad. Sci. USA 93:8884-8888.
43. Tasset, D., L. Tora, C. Fromental, E. Scheer, and P. Chambon. 1990. Distinct classes of transcriptional activating domains function by different mechanisms. Cell 62:1177-1187.
44. Voegel, J. J., M. J. S. Heine, C. Zechel, P. Chambon, and H. Gronemeyer. 1996. TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J. 15:101-108.
45. vom Baur, E., C. Zechel, D. Heery, M. J. S. Heine, J. M. Garnier, V. Vivat, B. Le Douarin, H. Gronemeyer, P. Chambon, and R. Losson. 1996. Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1. EMBO J. 15:110-124.
46. Wagner, R. L., J. W. Apriletti, M. E. McGrath, B. L. West, J. D. Baxter, and R. J. Fletterick. 1995. A structural role for hormone in the thyroid hormone receptor. Nature 378:690-697.
47. Webster, N. J., S. Green, D. Tasset, M. Ponglikitmongkol, and P. Chambon. 1989. The transcriptional activation function located in the hormone-binding domain of the human oestrogen receptor is not encoded in a single exon. EMBO J. 8:1441-1446.
48. White, R., S. Jobling, S. A. Hoare, J. P. Sumpter, and M. G. Parker. 1994. Environmentally persistent alkylphenolic compounds are estrogenic. Endocrinology 135:175-182.
49. Wurtz, J.-M., W. Bourguet, J.-P. Renaud, V. Vivat, P. Chambon, D. Moras, and H. Gronemeyer. 1996. A canonical structure for the ligand-binding domain of nuclear receptors. Nat. Struct. Biol. 3:87-94.
50. Zenke, M., A. Munoz, J. Sap, B. Vennström, and H. Beug. 1990. v-erbA oncogene activation entails the loss of hormone-dependent regulator activity of c-erbA. Cell 61:1035-1049.